Home » Posts tagged with » USA
Ligand Pharmaceuticals to acquire protein therapeutics developer Pfenex

Ligand Pharmaceuticals to acquire protein therapeutics developer Pfenex

US biopharma company Ligand Pharmaceuticals has signed a deal worth up to $516 million to acquire Pfenex, a development and licensing biotechnology company engaged in the development of protein therapeutics, which are used in various commercial and development-stage biopharma drug candidates. As per the terms of the deal, Ligand Pharmaceuticals is offering to acquire the […]

Bayer gets Lampit FDA approval for Chagas disease in pediatric patients

Lampit FDA approval : Bayer has bagged approval for its antiprotozoal medication Lampit (nifurtimox) from the US Food and Drug Administration (FDA) for the treatment of Chagas disease in pediatric patients, from newly born to less than 18 years of age, weighing at least 2.5kg. Chagas disease is an infectious tropical disease caused by Trypanosoma […]

Continue reading …
Cancer Targeted Technology gets NIH grant to support CTT1403 trial

Cancer Targeted Technology (CTT), a Seattle-based biotech company, has secured a grant of $1.44 million from the US National Institutes of Health (NIH) to support an ongoing clinical trial of a new radiotherapeutic called CTT1403 in prostate cancer. According to the company, the NIH grant has been awarded on the second year of a competitive […]

Continue reading …
Janssen Covid-19 vaccine candidate Ad26.COV2.S bags $1bn deal from US govt

Johnson & Johnson (J&J) said that its subsidiary Janssen Pharmaceutical has agreed to manufacture and supply 100 million doses of its SARS-CoV-2 investigational vaccine Ad26.COV2.S to the US government, in a deal worth more than $1 billion. The Janssen Covid-19 vaccine candidate will be supplied either after approval by the US Food and Drug Administration […]

Continue reading …
PIPE-505 : Pipeline Therapeutics initiates phase 1/2a SNHL trial

Pipeline Therapeutics has initiated a phase 1/2a trial of PIPE-505, which is a small molecule gamma secretase inhibitor (GSI), in patients who have sensorineural hearing loss (SNHL) associated with hearing speech in noisy environments. The phase 1/2a trial is anticipated to take in 24 adult patients, and will be carried out as a randomized, double-blind, […]

Continue reading …
Curi Bio acquires Dana Solutions to boost drug discovery platforms

Curi Bio, a developer of human iPSC-based platforms for drug discovery, has acquired Dana Solutions, a provider of artificial intelligence and machine learning technologies for in vitro cell-based assays. Financial terms of the deal were not disclosed by the parties. Curi Bio, through the acquisition, will get access to Dana Solutions’ artificial intelligence and machine […]

Continue reading …
Novavax NVX-CoV2373 COVID-19 vaccine candidate to be manufactured by FDB

Novavax has signed an agreement with FUJIFILM Diosynth Biotechnologies (FDB), a US-based contract development and manufacturing organization (CDMO), for the manufacturing of bulk drug substance for NVX-CoV2373, the former’s COVID-19 vaccine candidate. FUJIFILM Diosynth Biotechnologies’ facility in Morrisville, North Carolina has started production of the first batch of NVX-CoV2373. The arrangement between the two firms […]

Continue reading …
Ampio Pharmaceuticals begins phase 1 trial of Ampion for COVID-19 treatment

Ampio Pharmaceuticals has started a phase 1 clinical trial in the US for assessing its immunomodulatory anti-inflammatory agent Ampion as a five-day intravenous (IV) treatment for COVID-19 in adult patients who need supplemental oxygen. According to the Colorado-based biopharma company, the primary endpoint for the randomized, controlled study – NCT04456452 is the safety and tolerability […]

Continue reading …
BNT162 COVID-19 vaccine candidate : US govt signs $2bn supply deal with Pfizer and BioNTech

Pfizer and BioNTech have bagged a $1.95 billion deal with the US government for supplying 100 million doses of their jointly developed BNT162 COVID-19 vaccine candidate. Recently, the two pharma companies were granted the fast track designation from the US Food and Drug Administration (FDA) for BNT162b1 and BNT162b1 vaccines, which are two of the […]

Continue reading …
Tenzing to acquire clinical-stage pharma company Reviva Pharmaceuticals

Tenzing Acquisition has agreed to acquire Reviva Pharmaceuticals, a California-based clinical-stage pharma company, focused on developing therapies for addressing unmet medical needs in the areas of central nervous system, metabolic, cardiovascular, and inflammatory diseases. According to the British Virgin Islands-incorporated special purpose acquisition company, the equity value of the combined company post its merger with […]

Continue reading …
Page 1 of 36123Next ›Last »